PBIO — Pressure BioSciences Balance Sheet
0.000.00%
- $0.13m
- $28.74m
- $1.98m
Annual balance sheet for Pressure BioSciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.03 | 0.019 | 0.132 | 0.004 | 0.081 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.229 | 0.131 | 0.155 | 0.295 | 0.151 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1.09 | 1.06 | 1.86 | 1.24 | 0.76 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.132 | 0.238 | 0.511 | 0.385 | 0.228 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 1.82 | 2.3 | 2.83 | 2.01 | 1.05 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13.9 | 18.5 | 24.6 | 34.4 | 33.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 13.9 | 19.2 | 25 | 34.7 | 33.8 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -12.1 | -16.9 | -22.2 | -32.7 | -32.8 |
Total Liabilities & Shareholders' Equity | 1.82 | 2.3 | 2.83 | 2.01 | 1.05 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |